Literature DB >> 33466178

Examined lymph node count is not associated with prognosis in elderly patients with pN0 thoracic esophageal cancer.

Guoqing Zhang1, Xiaofeng Guo2, Lulu Yuan1, Zhen Gao1, Jindong Li1, Xiangnan Li1.   

Abstract

ABSTRACT: The purpose of this study was to determine whether the number of lymph nodes dissected predicts prognosis in surgically treated elderly patients with pN0 thoracic esophageal cancer. We searched the Surveillance, Epidemiology, and End Results database and identified the records of younger (<75 years) and older (≥75 years) patients with pN0 thoracic esophageal cancer between 1998 and 2015. The patient characteristics, tumor data, and postoperative variables were analyzed in this study. The Kaplan-Meier method and a Cox proportional hazard model were used to compare overall and cause-specific survival. Data from 1,792 esophageal cancer patients (older: n = 295; younger: n = 1497) were included. The survival analysis showed that the overall and cause-specific survival in the patients with ≥15 examined lymph nodes (eLNs) was significantly superior to that in the patients with 1 to 14 eLNs (P < .001); however, the difference disappeared in the older patients. After stratification by the tumor location, histology, pT classification, and differentiation between the younger and older cohorts to analyze the association between eLNs and survival, we found that the differences remained significant in most subgroups in the younger cohort. There were no differences in any subgroups of older patients. This study replicated the previously identified finding that long-term survival in patients with extensive lymphadenectomy was significantly superior to that in patients with less extensive lymphadenectomy. However, less extensive lymphadenectomy may be an acceptable treatment modality for elderly patients with pN0 thoracic esophageal cancer.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33466178      PMCID: PMC7808502          DOI: 10.1097/MD.0000000000024100

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  21 in total

1.  Detection and clinical significance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma.

Authors:  F Kijima; S Natsugoe; S Takao; K Aridome; M Baba; M Yoshifumi; Y Eizuru; T Aikou
Journal:  Oncology       Date:  2000       Impact factor: 2.935

2.  Prognostic value of lymph node count on survival in pathologically node-negative oesophageal squamous cell cancer.

Authors:  Yue Yu; Wei Wang; Qing Li; Fei Zhao; Yue Zhou; Jing Xu; Chenjun Huang
Journal:  Interact Cardiovasc Thorac Surg       Date:  2018-03-01

3.  Extent of lymph node removal during esophageal cancer surgery and survival.

Authors:  Maartje van der Schaaf; Asif Johar; Bas Wijnhoven; Pernilla Lagergren; Jesper Lagergren
Journal:  J Natl Cancer Inst       Date:  2015-03-05       Impact factor: 13.506

4.  Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma.

Authors:  F Sato; Y Shimada; Z Li; G Watanabe; M Maeda; M Imamura
Journal:  Br J Surg       Date:  2001-03       Impact factor: 6.939

5.  Extent of lymphadenectomy does not predict survival in patients treated with primary esophagectomy.

Authors:  Joyce Wong; Jill Weber; Khaldoun Almhanna; Sarah Hoffe; Ravi Shridhar; Richard Karl; Kenneth L Meredith
Journal:  J Gastrointest Surg       Date:  2013-07-02       Impact factor: 3.452

6.  Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.

Authors:  Alexander J Greenstein; Virginia R Litle; Scott J Swanson; Celia M Divino; Stuart Packer; Juan P Wisnivesky
Journal:  Cancer       Date:  2008-03-15       Impact factor: 6.860

7.  Optimum lymphadenectomy for esophageal cancer.

Authors:  Nabil P Rizk; Hemant Ishwaran; Thomas W Rice; Long-Qi Chen; Paul H Schipper; Kenneth A Kesler; Simon Law; Toni E M R Lerut; Carolyn E Reed; Jarmo A Salo; Walter J Scott; Wayne L Hofstetter; Thomas J Watson; Mark S Allen; Valerie W Rusch; Eugene H Blackstone
Journal:  Ann Surg       Date:  2010-01       Impact factor: 12.969

8.  Effect of lymph node examined count on accurate staging and survival of resected esophageal cancer.

Authors:  Wenjie Xia; Suyao Liu; Qixing Mao; Bing Chen; Weidong Ma; Gaochao Dong; Lin Xu; Feng Jiang
Journal:  Thorac Cancer       Date:  2019-04-07       Impact factor: 3.500

9.  Differences in Esophageal Cancer Surgery in Terms of Surgical Approach and Extent of Lymphadenectomy: Findings of an International Survey.

Authors:  A S van Rijswijk; E R C Hagens; D L van der Peet; M I van Berge Henegouwen; S S Gisbertz
Journal:  Ann Surg Oncol       Date:  2019-03-21       Impact factor: 5.344

10.  Esophageal cancer in elderly patients: a population-based study.

Authors:  Yuan Zeng; Wenhua Liang; Jun Liu; Jiaxi He; Calvin S H Ng; Chia-Chuan Liu; René Horsleben Petersen; Gaetano Rocco; Thomas D'Amico; Alessandro Brunelli; Haiquan Chen; Xiuyi Zhi; Xiao Dong; Wei Wang; Fei Cui; Dakai Xiao; Wenjun Wang; Wei Yang; Hui Pan; Jianxing He
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

View more
  1 in total

1.  Efficacy and safety of camrelizumab in combination with neoadjuvant chemotherapy for ESCC and its impact on esophagectomy.

Authors:  Yujin Qiao; Cong Zhao; Xiangnan Li; Jia Zhao; Qi Huang; Zheng Ding; Yan Zhang; Jia Jiao; Guoqing Zhang; Song Zhao
Journal:  Front Immunol       Date:  2022-07-14       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.